STATE STREET CORP - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 93 filers reported holding REGULUS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$5,000
-68.8%
23,941
-8.2%
0.00%
Q2 2018$16,000
-59.0%
26,075
-54.1%
0.00%
Q1 2018$39,000
-23.5%
56,779
+18.6%
0.00%
Q4 2017$51,000
+50.0%
47,869
+84.1%
0.00%
Q3 2017$34,000
+6.2%
26,000
-20.0%
0.00%
Q2 2017$32,000
-96.7%
32,500
-94.4%
0.00%
Q1 2017$959,000
-22.7%
580,549
+5.2%
0.00%
Q4 2016$1,240,000
-33.2%
551,941
-1.8%
0.00%
Q3 2016$1,856,000
+16.6%
562,328
+2.0%
0.00%
Q2 2016$1,592,000
-39.2%
551,539
+45.9%
0.00%
Q1 2016$2,618,000
-12.9%
377,896
+9.6%
0.00%
Q4 2015$3,006,000
+41.8%
344,677
+6.2%
0.00%
Q3 2015$2,120,000
-92.7%
324,565
-87.8%
0.00%
-100.0%
Q2 2015$29,145,000
+26.6%
2,659,285
+95.7%
0.00%
+50.0%
Q1 2015$23,016,000
+17.6%
1,358,746
+11.4%
0.00%0.0%
Q4 2014$19,566,000
+2167.2%
1,219,814
+865.5%
0.00%
Q3 2014$863,000
-5.2%
126,337
+11.5%
0.00%
Q2 2014$910,000
-17.1%
113,341
-7.0%
0.00%
Q1 2014$1,098,000
-0.6%
121,839
-20.0%
0.00%
Q4 2013$1,105,000
-16.0%
152,298
+9.1%
0.00%
Q3 2013$1,316,000
-7.4%
139,636
-3.5%
0.00%
Q2 2013$1,421,000144,6270.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
RA Capital Management 4,039,823$26,420,0003.79%
Foresite Capital Management II, LLC 1,750,269$11,447,0003.48%
ARGONAUT CAPITAL MANAGEMENT CORP 75,000$491,0001.65%
Abingworth LLP 327,350$2,138,0001.25%
Trellus Management Company, LLC 100,000$654,0000.96%
Cormorant Asset Management, LP 896,522$5,863,0000.94%
DAFNA Capital Management LLC 90,000$589,0000.58%
ORACLE INVESTMENT MANAGEMENT INC 749,064$4,898,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
View complete list of REGULUS THERAPEUTICS INC shareholders